Russia's sovereign wealth fund RDIF said on Thursday that it had agreed to manufacture Russia's first registered COVID-19 vaccine 'Sputnik-V' in Brazil. RDIF, which is backing the vaccine's development, also said it planned to supply up to 100 million doses of the vaccine to Latin America.